期刊
CELLULAR & MOLECULAR IMMUNOLOGY
卷 18, 期 2, 页码 259-268出版社
CHIN SOCIETY IMMUNOLOGY
DOI: 10.1038/s41423-020-00585-5
关键词
Aryl hydrocarbon receptor; Autoimmune diseases; Infectious diseases; cancer
类别
资金
- NIH [NS102807, ES02530, ES029136, AI126880]
- NMSS [RG-1902-33606]
- International Progressive MS Alliance [PA-1604-08459]
- Santander Universidades
- FundacAo Faculdade de Medicina (FFM), SAo Paulo, SP, Brazil
The aryl hydrocarbon receptor (AHR) was originally identified as the receptor for dioxin and is now known to be a receptor for multiple physiological ligands, playing crucial roles in health and disease. AHR has been found to play a role in the gut-brain axis and could hold potential as a therapeutic target for immune-mediated diseases.
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor initially identified as the receptor for dioxin. Almost half a century after its discovery, AHR is now recognized as a receptor for multiple physiological ligands, with important roles in health and disease. In this review, we discuss the role of AHR in the gut-brain axis and its potential value as a therapeutic target for immune-mediated diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据